Sandu Pharma: ₹2.63 Cr & ₹1.38 Cr Funds Utilized as Per Plan

Sandu Pharmaceuticals Ltd has filed a statement of deviation and utilization of funds for the quarter ended June 30, 2026. The company reported on the utilization of funds raised through a preferential issue of equity shares (private placement). For the first tranche, ₹2,63,79,653 was raised on March 31, 2021, and for the second tranche, ₹1,38,05,408 was raised on February 28, 2022. In both instances, the funds raised were fully utilized as per the original objects, which included revamping capital machinery, developing marketing infrastructure, civil work, purchasing plant and machinery, working capital, and general business enhancement. The Audit Committee has reviewed and approved the statement, with no comments from the auditors.